← All diseases
Cancer
Acute myeloid leukemia
Would you like to receive a message when there is new research on Acute myeloid leukemia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you will be notified as soon as new research on Acute myeloid leukemia is available. View what Premium costs.
Publications and studies (2129)
- Serum gamma-glutamyl transpeptidase/albumin ratio in patients with acute myeloid leukemia: a new perspective on prognostic assessment. (2026/12/01) ♡
- Phase angle as a nutritional assessment method in patients with acute myeloid leukemia: a cross-sectional study. (2026/12/01) ♡
- FLT3-ITD Measurable Residual Disease in Acute Myeloid Leukemia: Recommended, but Not Yet Self-Sufficient. (2026/09/01) ♡
- Defining a Therapeutic Window for Venetoclax in Post-Transplant Maintenance Therapy for High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes. (2026/09/01) ♡
- Targeting a CDH1-TK1-dependent DNA Synthesis Pathway Overcomes Chemoresistance in Acute Myeloid Leukemia. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond BCL-2: What drives venetoclax resistance in acute myeloid leukemia? (2026/08/10) ♡
- Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment. (2026/08/10) ♡
- Insights to provider practice of germline testing for inherited hematologic malignancy predisposition syndromes to inform hematopoietic stem cell transplantation. (2026/08/10) ♡
- The FOLR2-IRF2BP2 axis mediates erythropoiesis impairment by excess folic acid in myelodysplastic neoplasms. (2026/08/10) ♡
- Correction: CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia. (2026/08/10) ♡
- Implications of Incorporating Myelodysplasia-Related Gene Variant Data on Acute Myeloid Leukemia Reclassification According to WHO-HAEM5 and ICC: A Large Multicenter Korean Cohort Study. (2026/08/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute Myeloid Leukemia With Extreme Hypereosinophilia Without Canonical Genetic Drivers: A Diagnostic Challenge. (2026/08/09) ♡
- TP53-mutated Therapy-related Leukemia with the Der(5;17)(p10;q10) Chromosomal Abnormality Following Chemotherapy for Acute Promyelocytic Leukemia Bridged to Allogeneic Hematopoietic Stem Cell Transplantation Using CPX-351. (2026/08/08) ♡
- Transcriptome-Wide Cox Regression Identifies Candidate Survival-Associated Genes in Newly Diagnosed Acute Myeloid Leukemia. (2026/08/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Concurrent Germline RB1 & Mosaic TP53 in a Child With Multiple Childhood Cancers. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myeloid sarcoma: Clinical, Pathologic, and Molecular Findings. (2026/08/08) ♡
- Diagnostic Concordance and Superiority of Flow Cytometry Over Immunohistochemistry in Acute Leukemia Immunophenotyping: A Single-Center Study. (2026/08/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Relapsing-Remitting Perimyocarditis and Emerging Acute Myeloid Leukemia. (2026/08/07) ♡
- An integrated deep learning and molecular dynamics pipeline for the discovery of novel CDK8 inhibitors against acute myeloid leukaemia. (2026/08/07) ♡
- Synthesis of ACT-007 and Its Analogues with Antiproliferative Activity. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond nuclear export: chromatin-bound XPO1/CRM1 as a transcriptional scaffold. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Antigen Pressure, Clonal Evolution, and Lineage Plasticity in B-Cell Acute Lymphoblastic Leukemia: Resistance Biology in the Immunotherapy Era. (2026/08/07) ♡
- A phase II study of low dose melphalan with thiotepa and fludarabine as preparative regimen for alternative donor transplantation. (2026/08/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Mixed phenotype acute leukemia mimicking adult-onset Still's disease in a pregnant female: A rare case report. (2026/08/07) ♡
- Prognostic factors for early mortality following allogeneic hematopoietic cell transplantation in hematologic malignancies. (2026/08/07) ♡
- Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions. (2026/08/07) ♡
- Factors influencing patient preferences for pharmacological and non-pharmacological treatment options in chronic health conditions: a systematic review. (2026/08/06) ♡
- Exosomal PKM2 from AML cells reprograms endothelial metabolism to promote angiogenesis and chemoresistance. (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Breaking the relapse barrier: innovative approaches to improve CAR T-cell efficacy by targeting leukemic stem cells (LSCs) and measurable residual disease (MRD) in acute myeloid leukemia. (2026/08/06) ♡
- Expression of Peripheral Blood microRNA-126 and Its Prognostic Value in Patients With Acute Myeloid Leukemia. (2026/08/06) ♡
- Second primary malignancies among childhood medulloblastoma survivors: a population-based competing risk analysis. (2026/08/06) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The spatial and multi-omic landscape of Down syndrome leukemogenesis: moving beyond cellular heterogeneity. (2026/08/06) ♡
- Ki-67 Expression in megakaryocytes: A new prognostic marker in Myelodysplastic Syndromes. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. cGAS-STING signaling in acute myeloid leukemia: biology, pathophysiology and therapeutic implications. (2026/08/05) ♡
- An integrated automated pipeline for cloning, transient expression, and purification augmenting the plant cell pack platform for biopharmaceutical screening. (2026/08/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo). (2026/08/05) ♡
- The kinase CK1α coordinates the initiation and termination of the cGAS-STING pathway. (2026/08/05) ♡
- DNMT3A Co-Mutation and Real-World Clinical Outcomes With Gilteritinib in FLT3-Mutated Acute Myeloid Leukaemia Across Molecular Subgroups. (2026/08/05) ♡
- Dihydropyrimidinone-isatin hybrids as potent inducers of cell-cycle arrest and caspase-dependent apoptosis in MV4-11 acute myeloid leukemia cells. (2026/08/05) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy. (2026/08/05) ♡
- Stemness-driven INTS7 overexpression links metabolic comorbidity to chemoresistance in acute myeloid leukemia with type 2 diabetes. (2026/08/04) ♡
- Optical genome mapping refines diagnosis of high-grade myeloid neoplasms through detection of MECOM rearrangements cryptic to conventional karyotype. (2026/08/04) ♡
- Acute myeloid leukemia with 4q12 rearrangements involving CHIC2: "pitfalls" in fluorescence in situ hybridization diagnosis of PDGFRA rearrangements. (2026/08/04) ♡
- Boosting anti-leukemia cytotoxicity of CD4 and CD8 T cells through combined inhibition of MEK and HDAC. (2026/08/04) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Synchronous Metastatic Esophageal Squamous Cell Carcinoma and Acute Myeloid Leukemia: A Case Report. (2026/08/04) ♡
- A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells. (2026/08/03) ♡
- Myeloid-lineage blasts with histiocytoid differentiation in TP53 mutated acute myeloid leukemia: a deceptive morphologic overlap with mature malignant histiocytic neoplasms. (2026/08/03) ♡
- Analytical validation of a modified wild-type blocker qpcr assay for the sensitive DNA-based detection of NPM1 type A in acute myeloid leukemia. (2026/08/03) ♡
- Natural Killer Cell Immunotherapy After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia Patients: Phase I Clinical Trial. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification. (2026/08/03) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.